Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helper T Cell Type 2 to Helper T Cell Type 1 Switch (None)
- Target
- None
- Molecular classification
- Other
01
Overview
The Helper T cell type 2 to helper T cell type 1 switch refers to the process by which CD4+ T helper cells (Th2) committed to a type 2 immune response can be reprogrammed or redirected toward a type 1 (Th1) phenotype. This switch is significant in immunology because Th1 and Th2 cells orchestrate distinct immune responses: Th1 cells promote cellular immunity against intracellular pathogens, while Th2 cells support humoral immunity and are associated with allergic responses. The switch involves downregulation of GATA3/STAT6-driven programs and upregulation of T-bet/STAT4-driven programs under influence of environmental cues like increased levels of IFN-γ or therapeutic administration of cytokines such as IL-12.
02
Mechanism of action
Reprogramming CD4+ helper T cells from TH2 to TH1 phenotype through alteration of cytokine milieu and transcription factor activity.
03
Biological functions
Immune responseCell differentiationCytokine productionRegulation of immune response
04
Disease associations
InfectionAllergic diseasesAutoimmune diseases
05
Safety considerations
Potential for excessive Th1 response leading to immunopathologyCytokine stormExacerbation of autoimmune diseases
06
Interacting drugs
Interleukin-12
2 more in the full profile.
07
Biomarkers
IFN-γ levelsIL-4 levelsT-bet expressionGATA3 expressionSTAT4 activationSTAT6 activation
Beyond the preview
Go deeper on Helper T Cell Type 2 to Helper T Cell Type 1 Switch (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Helper T Cell Type 2 to Helper T Cell Type 1 Switch (None).